Search
Pancreatic Cancer Patient Exceeds Life Expectancy After Complex Whipple Procedure at UCSF
A team of UCSF surgeons devised a successful reconstruction approach during a complex Whipple procedure in a 69-year-old man with locally advanced pancreatic adenocarcinoma.Sorting Cancers by “Immune Archetypes” Represents Potential New Approach to Developing Precision Immunotherapies
Using data from over 300 patient tumors, UCSF researchers have described 12 classes of “immune archetypes” to classify cancer tumors. Their findings, published today in CELL, reveal that cancers from different parts of the body are immunologically similar to one another. These classifications provide unique strategies for enhancing each patient’s choice of cancer immunotherapies.UCSF Study Finds 25% of Patients with HPV+ Oropharynx Cancer May Require Chemoradiotherapy After Robotic Surgery
In a nearly 10-year retrospective study involving 136 carefully selected patients with HPV-positive (HPV+) oropharynx cancer, UC San Francisco researchers found that one in four may meet possible indications for adjuvant chemoradiotherapy following transoral robotic surgery (TORS).International Hematologic Conference Features UCSF Health Experts
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 63rd Annual Meeting and Exposition. This year’s meeting will be held in Atlanta, Georgia – and virtually – from December 11-14, 2021.International Breast Cancer Conference Features UCSF Health Experts
Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 7-10.UCSF-Led Study Confirms Some Cancer Immunotherapies May Lead to Myocarditis and Other Potentially Serious Arrhythmias
Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis.UCSF’s Lawrence Fong, MD, Earns NCI Award for Cancer Immunotherapy Research
The National Cancer Institute (NCI)has honored Lawrence H. Fong, MD, leader of the UC San Francisco Cancer Immunotherapy Program, with an Outstanding Investigator Award (R35).These awards support investigators who have significant records of productivity in cancer research with multiyear funding for projects of exceptional potential.An Extraordinary Response: A Young Woman’s Path to Overcoming Metastatic Colon Cancer
28-year-old woman mother of two was healthy up until a month prior, when she developed severe anemia, diarrhea and emesis, accompanied by a 25-pound weight loss.UCSF500 Cancer Gene Panel Test
The UCSF500 Cancer Gene Panel leverages world-class expertise for advanced cancer cases. Designed by our leading cancer specialists, the UCSF500 offers unparalleled depth and precision in genetic analysis.UCSF at the Forefront of New Therapies, Giving Hope to Multiple Myeloma Patients
Over the past few decades, advances in the treatment of multiple myeloma (MM) have accelerated at a thrilling pace, with a wealth of new therapeutic options now available for patients with this serious disease.Advances in Treating Colorectal Cancer With Liver Metastases
Giving new hope to potentially thousands of patients, surgeons at UC San Francisco are now providing lifesaving procedures for many colorectal cancer patients whose cancer has spread to the liver.UCSF Clinic Fills Unmet Need for Managing Oral Side Effects of Cancer Therapies
As advances in cancer treatments have expanded, so has the number of side effects that impact the mouth. Oral medicine specialists at UC San Francisco are working to mitigate these often-debilitating problems, which affect the majority of patients undergoing or recovering from cancer therapy.UCSF Oral Oncology
The UCSF Oral Oncology Clinic offers consultations for the diagnosis, treatment and management of oral complications from cancer treatment. The clinic is the first and only one of its kind in Northern California.UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.Post-Pandemic Cancer Care Delivery: Recovery or Redesign?
The COVID-19 pandemic has prompted major changes in the way clinicians deliver care, and nowhere have these changes been more urgent than in the field of oncology.Response to Cancer Immunotherapy May Be Affected by Genes We Carry from Birth
A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.UCSF Researchers Help Gain FDA Approval for Prostate Cancer Imaging Technique
Method is a ‘game changer’ that should become the standard of care, say UCSF researchers who validated its effectiveness.UCSF Ranked #10 for Cancer Care | Clinical Trials Update
We are pleased to announce that UCSF Medical Center has been recognized as the best hospital in Northern California for cancer care — and among the top 10 cancer programs nationally — by U.S. News & World Report’s 2020-21 survey of Best Hospitals.California Center for Pituitary Disorders
The California Center for Pituitary Disorders is the largest practice for pituitary disorders in the United States & performs more pituitary surgeries than any other medical center in the U.S.Cancer Services Referral Directory
One of the primary objectives at the UCSF Helen Diller Family Comprehensive Cancer Center is to be a partner in care, supporting patients’ treatments and providing physicians with efficient access to our services.2019-20 Referral Services Guide
UCSF Health is recognized throughout the world for innovative treatments, advanced technology, collaboration among clinicians and scientists, and a highly compassionate team of patient care providers.Oral Dysplasia Program
Oral dysplasia patients at UCSF benefit from an internationally recognized team of multidisciplinary experts with the highest level of expertise in this difficult-to-manage and often unpredictable disease.Pancreas Center
Novel therapeutics and state-of-the-art surgical techniques combined with an array of support services for patientsHematology and Blood and Marrow Transplant
Specialized treatments for acute and chronic blood conditions, from cancers to the full range of non-malignant blood disorders